Publicação

Epilepsy in neurodegenerative diseases: related drugs and molecular pathways

Ver documento

Detalhes bibliográficos
Resumo:Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.
Autores principais:Cano, Amanda
Outros Autores:Fonseca, Elena; Ettcheto, Miren; Sánchez-López, Elena; de Rojas, Itziar; Alonso-Lana, Silvia; Morató, Xavier; Souto, Eliana B.; Toledo, Manuel; Boada, Mercè; Marquié, Marta; Ruíz, Agustín
Assunto:Epilepsy Neurodegenerative diseases Alzheimers disease Parkinsons disease Huntingtons disease Multiple sclerosis
Ano:2021
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade do Minho
Idioma:inglês
Origem:RepositóriUM - Universidade do Minho
_version_ 1866875867355938816
author Cano, Amanda
author2 Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
author2_role author
author
author
author
author
author
author
author
author
author
author
author_facet Cano, Amanda
Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
author_role author
contributor_name_str_mv Universidade do Minho
country_str PT
creators_json_txt [{\"Person.name\":\"Cano, Amanda\"},{\"Person.name\":\"Fonseca, Elena\"},{\"Person.name\":\"Ettcheto, Miren\"},{\"Person.name\":\"Sánchez-López, Elena\"},{\"Person.name\":\"de Rojas, Itziar\"},{\"Person.name\":\"Alonso-Lana, Silvia\"},{\"Person.name\":\"Morató, Xavier\"},{\"Person.name\":\"Souto, Eliana B.\"},{\"Person.name\":\"Toledo, Manuel\"},{\"Person.name\":\"Boada, Mercè\"},{\"Person.name\":\"Marquié, Marta\"},{\"Person.name\":\"Ruíz, Agustín\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Universidade do Minho
datacite.creators.creator.creatorName.fl_str_mv Cano, Amanda
Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
datacite.date.Accepted.fl_str_mv 2021-10-18T00:00:00Z
datacite.date.available.fl_str_mv 2021-10-26T09:11:56Z
datacite.date.embargoed.fl_str_mv 2021-10-26T09:11:56Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Epilepsy
Neurodegenerative diseases
Alzheimers disease
Parkinsons disease
Huntingtons disease
Multiple sclerosis
datacite.titles.title.fl_str_mv Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
dc.contributor.none.fl_str_mv Universidade do Minho
dc.creator.none.fl_str_mv Cano, Amanda
Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
dc.date.Accepted.fl_str_mv 2021-10-18T00:00:00Z
dc.date.available.fl_str_mv 2021-10-26T09:11:56Z
dc.date.embargoed.fl_str_mv 2021-10-26T09:11:56Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv https://hdl.handle.net/1822/74518
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute (MDPI)
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Epilepsy
Neurodegenerative diseases
Alzheimers disease
Parkinsons disease
Huntingtons disease
Multiple sclerosis
dc.title.fl_str_mv Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://prod-dspace.uminho.pt/bitstreams/d5d2b415-3351-48ff-a9f7-9a453efdb5b4/download
id rum_7dc9dfd0542e2159d141837eef56277e
identifier.url.fl_str_mv https://hdl.handle.net/1822/74518
instacron_str repositorium
institution Universidade do Minho
instname_str Universidade do Minho
language eng
network_acronym_str rum
network_name_str RepositóriUM - Universidade do Minho
oai_identifier_str oai:repositorium.uminho.pt:1822/74518
organization_str_mv urn:organizationAcronym:repositorium
person_str_mv Cano, Amanda
Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
publishDate 2021
publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute (MDPI)
reponame_str RepositóriUM - Universidade do Minho
repository_id_str urn:repositoryAcronym:rum
service_str_mv urn:repositoryAcronym:rum
spelling engMultidisciplinary Digital Publishing Institute (MDPI)porEpilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.application/pdfporEpilepsy in neurodegenerative diseases: related drugs and molecular pathwaysCano, AmandaFonseca, ElenaEttcheto, MirenSánchez-López, Elenade Rojas, ItziarAlonso-Lana, SilviaMorató, XavierSouto, Eliana B.Toledo, ManuelBoada, MercèMarquié, MartaRuíz, AgustínHostingInstitutionOrganizationalUniversidade do Minhoe-mailmailto:repositorium@usdb.uminho.ptrepositorium@usdb.uminho.ptDOIIsPartOf10.3390/ph141010572021-10-26T09:11:56Z2021-10-182021-092021-10-26T08:28:43Z2021-10-18T00:00:00ZHandlehttps://hdl.handle.net/1822/74518http://purl.org/coar/access_right/c_abf2open accessEpilepsyNeurodegenerative diseasesAlzheimers diseaseParkinsons diseaseHuntingtons diseaseMultiple sclerosis5202333 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://prod-dspace.uminho.pt/bitstreams/d5d2b415-3351-48ff-a9f7-9a453efdb5b4/download
spellingShingle Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
Cano, Amanda
Epilepsy
Neurodegenerative diseases
Alzheimers disease
Parkinsons disease
Huntingtons disease
Multiple sclerosis
status SINGLETON
subject.fl_str_mv Epilepsy
Neurodegenerative diseases
Alzheimers disease
Parkinsons disease
Huntingtons disease
Multiple sclerosis
title Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
title_full Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
title_fullStr Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
title_full_unstemmed Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
title_short Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
title_sort Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
topic Epilepsy
Neurodegenerative diseases
Alzheimers disease
Parkinsons disease
Huntingtons disease
Multiple sclerosis
topic_facet Epilepsy
Neurodegenerative diseases
Alzheimers disease
Parkinsons disease
Huntingtons disease
Multiple sclerosis
url https://hdl.handle.net/1822/74518
visible 1